RxDoctor Payments Data

Brian Sleasman, MD

Foot and Ankle Surgery · Chicago, ILNPI 1215386628

Payments from drug & device makers

$14,426in general payments, 2019–2025

Across 99 payments — averaging $145.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • Stryker$3K
  • Foundation Medical, LLC$3K
  • Medwest Associates$1K
  • Paragon 28, Inc.$1K
  • Medical Device Business Services, Inc.$685
  • plus $837 from 6 others

What the payments were for

  • Travel & lodging$3,75226%
  • Food & beverage$4,83233%
  • Education$5,84341%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex33$4,658
Stryker29$3,115
Foundation Medical, LLC12$2,840
Medwest Associates1$1,200
Paragon 28, Inc.11$1,092
Medical Device Business Services, Inc.4$685
Orthofix Medical, Inc.3$197
Zimmer Biomet2$149
Smith+Nephew1$145
Johnson & Johnson1$119
Gemini Medical LLC1$119
Axogen1$108

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,426 in reported general payments places this provider in the 85th percentile of 555 foot and ankle surgery providers in Illinois.

See all foot and ankle surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$25,353
Medicare patients
82
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam79$324

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →